[wp_ulike_counter]
Omeprazole injection 40 mg is a proton pump inhibitor (PPI) given by a healthcare professional into a vein (intravenously) to quickly reduce stomach acid. It is used for bleeding or severe stomach and duodenal ulcers, severe GERD with oesophagitis and Zollinger-Ellison syndrome, mainly when a patient cannot take omeprazole by mouth. It is commonly written as “Inj Omeprazole 40 mg”. This guide covers the uses, dose, how the injection is given, side effects, precautions and the difference between omeprazole injection and oral omeprazole 40 mg DR capsules. What Is Omeprazole Injection? Omeprazole injection is a sterile white to off-white lyophilised powder supplied in a vial (usually 40 mg per vial). It is reconstituted with a suitable diluent before use. Omeprazole belongs to the proton pump inhibitor class. It blocks the final step of acid production in the stomach lining, which lowers acidity and gives ulcers and inflamed tissue time to heal. Because it goes straight into the bloodstream, it works faster and more reliably than capsules in hospitalised or critically ill patients. Omeprazole Injection Uses Omeprazole 40 mg injection is prescribed in hospitals and clinics for: Active duodenal ulcer and gastric ulcer: especially when the ulcer is bleeding or causing severe erosions. Gastro-oesophageal reflux disease (GERD) with erosive oesophagitis: when oral treatment is not possible. Zollinger-Ellison syndrome: a condition where gastrin-producing tumours cause very high acid secretion. Prevention of acid aspiration: in some patients undergoing surgery or anaesthesia, as decided by the doctor. Patients who cannot swallow or take oral medicines: for example after surgery, in intensive care or with severe vomiting. Once the patient can swallow, doctors usually switch from the injection to an oral PPI. Inj Omeprazole 40 mg Dose and How It Is Given The dose is always decided by the treating doctor based on the condition, age, weight and liver function. As per standard prescribing information, the usual adult approach is: General adult dose: 40 mg once daily. Zollinger-Ellison syndrome: a higher starting dose may be used (commonly 60 mg once daily), adjusted by the doctor. Children: dosing is weight-based and must be set by a paediatric specialist. Liver impairment: dose reduction may be required. How it is administered: The vial is reconstituted by a trained healthcare professional using the diluent specified in the product leaflet. It is given as a slow intravenous injection or as an intravenous infusion over about 20 to 30 minutes, as directed by the doctor. It must not be given into a muscle (intramuscular) and should never be self-administered. Reconstituted solution should be used within the time limit stated in the product leaflet. Always follow the approved prescribing information of the specific product and your doctor’s instructions. Omeprazole 40 mg Injection Side Effects Most people tolerate omeprazole injection well. Side effects are usually mild and short-lived. Common side effects Headache Nausea or vomiting Diarrhoea or constipation Stomach pain or gas Pain, redness or swelling at the injection site Less common side effects Dizziness or sleep disturbance Skin rash or itching Taste changes Joint or muscle pain Serious side effects (seek medical help immediately) Severe allergic reaction: swelling of the face or throat, difficulty breathing Severe or persistent diarrhoea (possible Clostridioides difficile infection) Irregular heartbeat, muscle cramps or weakness (possible low magnesium or low sodium) Skin rash that worsens in sunlight (possible lupus-type reaction) Reduced urine output or swelling (possible kidney inflammation) With long-term PPI use, doctors also monitor for vitamin B12 deficiency, low magnesium and a higher risk of bone fractures. Who Should Not Use Omeprazole Injection? Precautions Anyone allergic to omeprazole or other PPIs (such as pantoprazole or esomeprazole). Patients taking nelfinavir or rilpivirine, since omeprazole can reduce their effect. Use with caution in liver disease, osteoporosis, low magnesium and colitis or chronic diarrhoea. Tell the doctor about all medicines you take. Omeprazole can interact with clopidogrel, warfarin, diazepam, phenytoin, methotrexate and digoxin, among others. Pregnancy and breastfeeding: use only if the doctor decides the benefit outweighs the risk. Alcohol: no direct interaction is established, but alcohol irritates the stomach and works against ulcer healing.  Omeprazole Injection vs Omeprazole 40 mg DR Capsule Many people search for “omeprazole 40 mg” or “omeprazole DR 40 mg”. These are usually oral delayed-release capsules, which are different from the injection. Feature Omeprazole Injection 40 mg Omeprazole DR 40 mg Capsule Route Intravenous (IV) Oral Given by Healthcare professional Patient (as prescribed) Onset Faster Slower Used when Patient cannot swallow, severe or bleeding ulcers, hospital care Routine ulcer, GERD and acidity treatment Form Lyophilised powder vial Delayed-release capsule Lifestyle Tips While Being Treated for Acid-Related Conditions Avoid spicy, oily and fried food. Limit alcohol, tea, coffee and cola drinks. Eat small, regular meals and finish dinner 2 to 3 hours before sleeping. Avoid smoking and long-term use of painkillers (NSAIDs) unless prescribed. Raise the head of the bed if you suffer from night-time reflux. Frequently Asked Questions (FAQs) What is omeprazole injection used for?It is used to treat bleeding or severe stomach and duodenal ulcers, severe GERD with oesophagitis and Zollinger-Ellison syndrome, especially when oral medicines cannot be taken. Is omeprazole 40 mg injection given IV or IM?It is given only intravenously, as a slow injection or short infusion, by a healthcare professional. It is not given into a muscle. What are the side effects of omeprazole injection?Common side effects include headache, nausea, diarrhoea, stomach pain and pain at the injection site. Serious but rare effects include severe allergic reactions and severe diarrhoea. What is the difference between omeprazole injection and omeprazole DR 40 mg?The injection is given into a vein in a hospital and acts faster. Omeprazole DR 40 mg is an oral delayed-release capsule taken by mouth for routine treatment. Can omeprazole injection be taken at home?No. It should be administered only by a trained healthcare professional. Omeprazole Injection Manufacturer and Exporter in India Salvavidas Pharmaceutical Pvt. Ltd. is a WHO-GMP certified pharmaceutical manufacturer and exporter based in Surat, Gujarat, supplying finished formulations, including injectables, to international markets. Looking for
[wp_ulike_counter]
0
Ceftriaxone for injection is a widely used antibiotic given by healthcare professionals to treat serious bacterial infections. This page explains what it is used for, the key safety points, and what hospitals, distributors and importers should check when sourcing ceftriaxone injection from India. Salvavidas Pharma is a WHO-GMP certified pharmaceutical manufacturer and exporter based in Surat, Gujarat, India. This page is for general information and trade enquiries. It does not replace the approved prescribing information or advice from a doctor or pharmacist. Quick Facts Item Details Product Ceftriaxone for injection (ceftriaxone sodium), powder for solution for injection or infusion Brand Name SALCEF Manufacturer SALVAVIDAS PHARMACEUTICAL Injection Site IV & IM Form Powder Packaging Type Vial Composition Ceftriaxone For Injection USP Country of Origin Made in India What Is Ceftriaxone? Ceftriaxone is an antibiotic from the cephalosporin group. It works by stopping bacteria from building their cell walls, which kills the bacteria or stops them from multiplying. It comes as a sterile powder that is mixed with a suitable liquid just before it is given. Because it is injected, it is used in hospitals and clinics under medical supervision, not for self-treatment. Like all antibiotics, it works only against bacterial infections and does not treat viral illnesses such as colds or flu. What Is Ceftriaxone Injection Used For? According to typical prescribing information, ceftriaxone may be used to treat infections such as: bacterial meningitis pneumonia and other lower respiratory tract infections middle ear infections (otitis media) urinary tract infections bone and joint infections skin and soft tissue infections certain other infections, and prevention of infection before some surgeries, as set out in the label The exact list of approved uses varies by product and country, so always refer to the label approved for your market. How Is It Given? Ceftriaxone is prepared and given by trained healthcare professionals. Key points from typical prescribing information: It can be given into a vein (injection or infusion) or deep into a muscle. The dose depends on the type and severity of infection and on the patient’s age, weight and condition. The prescriber decides the dose. Dose numbers are intentionally not listed on this page. For injection into a muscle, a lidocaine solution is often used to dissolve the powder to reduce pain. Lidocaine solution must never be given into a vein, and patients allergic to lidocaine need a different approach. Calcium-containing liquids, such as Ringer’s solution or Hartmann’s solution, must not be used to dissolve or dilute ceftriaxone, because a precipitate can form. The full course should be completed as prescribed. Antibiotics should only be used when prescribed, to reduce antibiotic resistance. Important Safety Information Prescribing information for ceftriaxone highlights points such as: Allergy: it must not be used in patients with serious allergy to ceftriaxone, other cephalosporins or, depending on the label, other beta-lactam antibiotics. Severe allergic reactions can occur. Newborns and calcium: ceftriaxone must not be given to premature newborns up to a defined corrected age, or to newborns (28 days or younger) who need, or are expected to need, calcium-containing intravenous solutions, because of the risk of ceftriaxone-calcium precipitation in the lungs and kidneys. Antibiotic-associated diarrhoea: severe or persistent diarrhoea, including Clostridioides difficile infection, can occur during or after treatment. Gallbladder and kidneys: ceftriaxone can form deposits in the gallbladder or kidneys in some patients. Blood tests: it can affect blood counts and some laboratory tests, such as urine glucose tests. Liver and kidney disease, pregnancy and breastfeeding: use needs careful medical assessment and follows the approved label. A doctor or pharmacist must decide whether ceftriaxone is suitable for a particular patient. Possible Side Effects Many people have no serious side effects. Common effects listed in labels include pain, redness or swelling at the injection site, diarrhoea or loose stools, rash and changes in blood or liver test results. Rare but serious reactions include severe allergic reactions, severe skin reactions, serious diarrhoea and blood problems. Anyone receiving ceftriaxone who has difficulty breathing, swelling of the face or throat, a severe rash, severe or bloody diarrhoea, or other worrying symptoms should seek medical help immediately. See the approved label for the complete list. What Buyers Should Check When Sourcing Ceftriaxone Injection Sterile antibiotic powders carry strict quality requirements. When you compare suppliers, ask about: Cephalosporin segregation: whether production uses dedicated or fully segregated areas and air handling to prevent cross-contamination with other products. Sterile manufacturing: the filling process, environmental monitoring and sterility assurance. Release testing: sterility, bacterial endotoxins, assay, related substances, water content, particulate matter, and clarity and colour of the reconstituted solution. Stability data: studies that suit your climate zone. Many African markets fall under ICH Zones IVa and IVb. Packaging: vial, stopper and seal quality, labelling that clearly states strength, and any diluent supplied. Batch documentation: Certificate of Analysis for each batch and traceable batch records. Storage and shipping: the labelled storage conditions and transport method. Export Documents and Regulatory Support Regulators in markets such as Nigeria (NAFDAC), Kenya (Pharmacy and Poisons Board) and Ghana (Ghana FDA) have their own registration rules. Depending on the market, buyers typically need: a valid GMP certificate for the manufacturing site a registration dossier in the format the regulator requests Certificates of Analysis for each batch a Certificate of Pharmaceutical Product (CoPP), where applicable labelling and packaging that meet local requirements Learn more about our regulatory services. Why Source from Salvavidas Pharma? WHO-GMP certified pharmaceutical manufacturer in Surat, Gujarat, India Experience supplying export markets, with a focus on Nigeria, Kenya, Ghana and other African countries Range across finished dosage forms and APIs, including generics, oncology and anti-HIV/ARV products Documentation support for registration and tenders See our manufacturing facility, finished formulations and global presence, or download our company profile. How to Order Send your enquiry: strength, pack, quantity and target country. Confirm specifications: pack type, shelf life, labelling and documents required. Receive a quotation: price, MOQ, lead time and payment terms. Review documents and samples: GMP certificate, specification and, where available, sample documents. Place
[wp_ulike_counter]
0
The pharmaceutical industry in India is one of the largest in the world, supplying affordable medicines to more than 200 markets. It is known as the pharmacy of the world because of its strength in generic medicines, vaccines, active pharmaceutical ingredients (APIs) and contract manufacturing. This guide explains how big the Indian pharmaceutical industry is, what it exports and where, the main challenges it faces, and the opportunities ahead, using recent, sourced data. It also covers what the industry’s growth means for importers and distributors, especially in Africa. Key Facts at a Glance Indicator Figure Source and period Size of the Indian pharma industry About US$60 billion Pharmexcil, April 2026 Projected size by 2030 US$130 billion Pharmexcil, April 2026; Economic Survey 2025-26 Pharma exports, FY2024-25 US$30.47 billion (up 9.4%) Pharmexcil handbook Pharma exports, FY2025-26 Above US$31 billion DGCIS data, reported May 2026 Pharma exports, April-June 2026 (Q1 FY27) US$8.10 billion (up 6.8%) Pharmexcil, August 2026 Global rank by production volume Third Pharmexcil chairman, April 2026 Global rank by export value 11th Economic Survey 2025-26 (PIB summary) Export destinations More than 200 markets Pharmexcil, April 2026 Share of exports to highly regulated markets More than 60% Pharmexcil, April 2026 How Big Is the Indian Pharmaceutical Industry? The Indian pharmaceutical industry is valued at around US$60 billion, according to Pharmexcil (the Pharmaceuticals Export Promotion Council of India), and is projected to reach US$130 billion by 2030. It is worth separating two rankings that are often mixed up. India is generally described as third in the world by volume of pharmaceutical production. By value of exports it ranks lower (11th, as summarised from the Economic Survey 2025-26), because much of what India makes is affordable generic medicine. A Short History Before 1970: foreign companies dominated the Indian market and domestic competition was limited. 1970 onwards: the Indian Patents Act of 1970 recognised process patents rather than product patents for medicines. This helped local companies build skills in reverse-engineering and producing generics, and exports began to grow. 1990s: economic liberalisation encouraged Indian companies to expand abroad and invest in quality and facilities. 2005: an amendment to the Patents Act introduced product patents, in line with international trade rules. Indian companies adapted by strengthening R&D, regulatory skills and partnerships. What India Makes and Exports India’s pharmaceutical output covers several product groups: Generic formulations: tablets, capsules, injectables, syrups and other finished dosage forms APIs and bulk drugs: the active ingredients used to make medicines Vaccines and biologicals Contract and third-party manufacturing for other companies’ brands Formulations and biologicals form the largest part of exports. In FY2024-25 drug formulations and biologicals accounted for about 75% of exports (US$22.93 billion) and bulk drugs for US$4.87 billion. In FY2025-26 formulations and biologicals contributed US$23.08 billion, about 74.2% of the total, and vaccines were the fastest-growing category at about US$1.5 billion, up 26.4%. Where Does India Export? The United States is India’s largest single market, accounting for about 31% of exports in April-June 2026. North America, Europe, Africa and Latin America together account for nearly 75% of exports. Export growth has not been smooth. In March 2026 exports fell about 23% from the previous March, which industry leaders linked to US stockpiling ahead of tariffs. Even so, FY2025-26 exports crossed US$31 billion, and growth continued in Q1 FY27. India and Africa Africa is a major and growing destination for Indian medicines. In FY2024-25 it accounted for about 12.9% of India’s pharmaceutical exports, and exports to Africa rose about 13% in FY2025-26. For African importers, the strengths of Indian suppliers include a wide product range, competitive pricing and manufacturers with WHO-GMP certification. Registration is handled country by country, by regulators such as NAFDAC in Nigeria, the Pharmacy and Poisons Board in Kenya and the Ghana FDA. Buyers should check that a supplier can provide a valid GMP certificate, batch Certificates of Analysis and the dossier format their regulator requires. Key Challenges Facing the Industry Price pressure. Domestic price controls and global competition on generics keep margins tight. Trade and tariff volatility. The March 2026 export decline shows how sensitive exports can be to US tariffs and inventory cycles. Dependence on imported inputs. Many manufacturers rely on imported APIs and key starting materials for some products. Quality and regulatory compliance. Meeting GMP standards across many markets requires continuous investment in quality systems. Rising compliance and sustainability costs. Environmental rules, data integrity requirements and audits add cost and complexity. Innovation gap. The industry is strongest in generics, and moving into complex generics, biosimilars and new drugs needs higher R&D spending. Key Opportunities A growing home market. Rising incomes, insurance coverage and healthcare infrastructure support demand, with the industry projected to reach US$130 billion by 2030. Vaccines and biologicals. These were the fastest-growing export categories in FY2025-26. Africa and other emerging markets. Exports to Africa, Oceania and Latin America grew faster than the overall total in FY2025-26. Trade agreements. The government highlights the India-UK CETA, the India-EU FTA and the EFTA agreement as opening new access for pharmaceutical exports. Contract and third-party manufacturing. Global and regional brands increasingly outsource manufacturing to qualified Indian plants. Policy support. Government programmes support domestic manufacturing of bulk drugs and medical products. Leading Indian Pharma Companies India’s pharmaceutical sector includes large listed companies and thousands of small and mid-sized manufacturers. Well-known names include Sun Pharma, Cipla, Dr. Reddy’s, Lupin, Zydus, Aurobindo Pharma, Divi’s Laboratories and Glenmark. Rankings change every year with revenue and market capitalisation, so check a current source before comparing companies. What This Means for Importers and Distributors If you plan to source medicines from India, look beyond price. Check: a valid manufacturing licence and WHO-GMP certificate the dosage forms and therapy areas the plant is approved for quality control, stability data and batch documentation regulatory support for your country’s registration process minimum order quantity, lead time and payment terms For a deeper look, read our guides to choosing a pharma contract manufacturer in India and third-party pharma manufacturing in India. About Salvavidas Pharma Salvavidas Pharma
0